CRISPR/Cas9 Genome Editing Vs. Over-Expression for Fluorescent Extracellular Vesicle-Labeling: A Quantitative Analysis
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Over-expression of fluorescently-labeled markers for extracellular vesicles is frequently used to visualize vesicle up-take and transport. EVs that are labeled by over-expression show considerable heterogeneity regarding the number of fluorophores on single particles, which could potentially bias tracking and up-take studies in favor of more strongly-labeled particles. To avoid the potential artefacts that are caused by over-expression, we developed a genome editing approach for the fluorescent labeling of the extracellular vesicle marker CD63 with green fluorescent protein using the CRISPR/Cas9 technology. Using single-molecule sensitive fluorescence microscopy, we quantitatively compared the degree of labeling of secreted small extracellular vesicles from conventional over-expression and the CRISPR/Cas9 approach with true single-particle measurements. With our analysis, we can demonstrate a larger fraction of single-GFP-labeled EVs in the EVs that were isolated from CRISPR/Cas9-modified cells (83%) compared to EVs that were isolated from GFP-CD63 over-expressing cells (36%). Despite only single-GFP-labeling, CRISPR-EVs can be detected and discriminated from auto-fluorescence after their up-take into cells. To demonstrate the flexibility of the CRISPR/Cas9 genome editing method, we fluorescently labeled EVs using the HaloTag with lipid membrane permeable dye, JaneliaFluor 646, which allowed us to perform 3D-localization microscopy of single EVs taken up by the cultured cells.
Tracking the uptake of labelled host-derived extracellular vesicles by the human fungal pathogen .
Visser C, Rivieccio F, Kruger T, Schmidt F, Cseresnyes Z, Rohde M Microlife. 2024; 5:uqae022.
PMID: 39660046 PMC: 11631206. DOI: 10.1093/femsml/uqae022.
Multiphoton lithography with protein photoresists.
Sivun D, Murtezi E, Karimian T, Hurab K, Marefat M, Klimareva E Mater Today Bio. 2024; 25:100994.
PMID: 38384793 PMC: 10879783. DOI: 10.1016/j.mtbio.2024.100994.
Lin J, Jia S, Jiao Z, Chen J, Li W, Cao F Cell Mol Biol Lett. 2023; 28(1):99.
PMID: 38041049 PMC: 10693129. DOI: 10.1186/s11658-023-00507-z.
CRISPR-Cas9 delivery strategies with engineered extracellular vesicles.
Lu Y, Godbout K, Lamothe G, Tremblay J Mol Ther Nucleic Acids. 2023; 34:102040.
PMID: 37842166 PMC: 10571031. DOI: 10.1016/j.omtn.2023.102040.
Aafreen S, Feng J, Wang W, Liu G Extracell Vesicles Circ Nucl Acids. 2023; 4(1):107-132.
PMID: 37829171 PMC: 10568980. DOI: 10.20517/evcna.2023.01.